Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Swanton

Showing results (331-340 of 440) with videos related to

Pageof 44
Sort By:
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
The New England Journal of Medicine|March 9, 2012
Intratumor heterogeneity and branched evolution revealed by multiregion sequencingMarco Gerlinger, Andrew J Rowan, Stuart Horswell, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Lancet (London, England)|October 18, 2020
Scientific consensus on the COVID-19 pandemic: we need to act nowNisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Nature Cancer|May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLCAaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.
Pageof 44

Showing results (331-340 of 440) with videos related to

Sort By:
Pageof 44
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
The New England Journal of Medicine|March 9, 2012
Intratumor heterogeneity and branched evolution revealed by multiregion sequencingMarco Gerlinger, Andrew J Rowan, Stuart Horswell, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Lancet (London, England)|October 18, 2020
Scientific consensus on the COVID-19 pandemic: we need to act nowNisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Nature Cancer|May 22, 2023
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLCAaron Javitt, Merav D Shmueli, Matthias P Kramer, et al.
Pageof 44